Biophytis (BPTSY) Competitors $2.00 0.00 (0.00%) As of 10/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock BPTSY vs. PRFX, SLXN, VRAX, GLMD, VAXX, UPC, GTBP, ATXI, WINT, and ELABShould you be buying Biophytis stock or one of its competitors? The main competitors of Biophytis include PainReform (PRFX), Silexion Therapeutics (SLXN), Virax Biolabs Group (VRAX), Galmed Pharmaceuticals (GLMD), Vaxxinity (VAXX), Universe Pharmaceuticals (UPC), GT Biopharma (GTBP), Avenue Therapeutics (ATXI), Windtree Therapeutics (WINT), and PMGC (ELAB). These companies are all part of the "pharmaceutical products" industry. Biophytis vs. Its Competitors PainReform Silexion Therapeutics Virax Biolabs Group Galmed Pharmaceuticals Vaxxinity Universe Pharmaceuticals GT Biopharma Avenue Therapeutics Windtree Therapeutics PMGC Biophytis (NASDAQ:BPTSY) and PainReform (NASDAQ:PRFX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership. Which has more risk & volatility, BPTSY or PRFX? Biophytis has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, PainReform has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500. Do analysts prefer BPTSY or PRFX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biophytis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00PainReform 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Which has higher earnings and valuation, BPTSY or PRFX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiophytisN/AN/A-$18.43MN/AN/APainReformN/AN/A-$14.59M-$147.33-0.01 Does the media prefer BPTSY or PRFX? In the previous week, PainReform had 4 more articles in the media than Biophytis. MarketBeat recorded 4 mentions for PainReform and 0 mentions for Biophytis. PainReform's average media sentiment score of 0.75 beat Biophytis' score of 0.00 indicating that PainReform is being referred to more favorably in the news media. Company Overall Sentiment Biophytis Neutral PainReform Positive Is BPTSY or PRFX more profitable? Company Net Margins Return on Equity Return on Assets BiophytisN/A N/A N/A PainReform N/A N/A N/A Do institutionals & insiders have more ownership in BPTSY or PRFX? 0.1% of Biophytis shares are held by institutional investors. Comparatively, 37.3% of PainReform shares are held by institutional investors. 3.7% of Biophytis shares are held by company insiders. Comparatively, 34.4% of PainReform shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryPainReform beats Biophytis on 6 of the 7 factors compared between the two stocks. Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTSY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BPTSY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BPTSY vs. The Competition Export to ExcelMetricBiophytisPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$702K$1.07B$6.16B$10.58BDividend YieldN/A4.84%5.66%4.69%P/E RatioN/A1.1165.0423.37Price / SalesN/A28.67612.06135.37Price / CashN/A17.6426.3031.10Price / Book-0.127.4712.876.67Net Income-$18.43M-$7.77M$3.30B$276.23M7 Day PerformanceN/A20.73%4.80%3.31%1 Month PerformanceN/A25.14%8.11%10.76%1 Year Performance-59.02%55.55%75.85%33.58% Biophytis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BPTSYBiophytisN/A$2.00flatN/AN/A$702KN/A0.0030PRFXPainReform1.5536 of 5 stars$1.36-1.4%N/A-46.2%$2.78MN/A-0.014News CoverageAnalyst UpgradeShort Interest ↓SLXNSilexion Therapeutics2.0664 of 5 stars$3.77-0.5%$75.00+1,889.4%-93.7%$2.77MN/A0.00N/AVRAXVirax Biolabs Group2.9944 of 5 stars$0.61-1.4%$3.00+391.3%-68.2%$2.69M$6.33K0.005Positive NewsGLMDGalmed Pharmaceuticals2.1476 of 5 stars$1.57+1.3%N/A-62.6%$2.56MN/A-0.0920Positive NewsShort Interest ↓Gap DownVAXXVaxxinityN/A$0.00-99.5%N/A+4,900.0%$2.54MN/A0.0090Gap UpUPCUniverse PharmaceuticalsN/A$4.49+2.0%N/AN/A$2.53M$19.29M0.00220Gap UpGTBPGT Biopharma1.6041 of 5 stars$0.64-1.7%$11.00+1,621.7%-68.4%$2.31MN/A-0.168News CoverageShort Interest ↑Gap UpATXIAvenue Therapeutics2.1952 of 5 stars$0.75+3.9%N/A-66.3%$2.29MN/A0.044WINTWindtree Therapeutics2.0759 of 5 stars$0.08+10.3%$350.00+465,945.3%-99.9%$2.20MN/A0.0030Gap UpELABPMGC1.0372 of 5 stars$5.44+5.2%N/A-99.0%$2.20M$1.71M-0.0118 Related Companies and Tools Related Companies PainReform Alternatives Silexion Therapeutics Alternatives Virax Biolabs Group Alternatives Galmed Pharmaceuticals Alternatives Vaxxinity Alternatives Universe Pharmaceuticals Alternatives GT Biopharma Alternatives Avenue Therapeutics Alternatives Windtree Therapeutics Alternatives PMGC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BPTSY) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biophytis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biophytis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
